The course Psychedelic Psychopharmacology is designed for healthcare professionals, graduate students, researchers, or the general public with an interest in the biological responses that influence the efficacy and safety of psychedelic therapy.
Fluence
English
12 Weeks
The course Psychedelic Psychopharmacology is designed for healthcare professionals, graduate students, researchers, or the general public with an interest in the biological responses that influence the efficacy and safety of psychedelic therapy. Over the course of 12 weeks, participants will engage in a reading and study group that will provide a comprehensive overview of the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Readings will include academic literature on several types of psychedelics, including psilocybin, ayahuasca, MDMA, and ketamine, and discussions will be led by a group leader. Weekly participation is required, and the format of each session will include a short review of each paper and group discussions on the topic.
By the end of the course, participants will be able to describe the pharmacokinetic properties of various psychedelics, explain how their pharmacodynamics affect clinical and serological biomarkers, and discuss their effects on neural network function. This knowledge will help healthcare professionals incorporate the tools and practices offered in this program in ways that are beneficial to their clients or patients.
This course was given each quarter and qualifies for 15 continuing education (CE) hours.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
This listing is marked as Professional course in Ketamine Therapy, MDMA Therapy, Psilocybin Therapy, Plant Medicine & Ayahuasca, Clinical & Medical, Research & Science. Check the provider page for final admission or eligibility details.
Format: Live Classes. Time commitment: 12 Weeks.
The listed price is $1,200. Confirm the latest tuition, fees, and payment options with [object Object].
Accreditation note: CE. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. The course website was not reachable in the latest check, so use the provider or similar-course links as a backup.
By Instituto Alma Viva
Same course category
Explore the first MEC-approved Postgraduate Course in Psychedelic-Assisted Psychotherapy in Brazil, designed for psychologists and psychiatrists. Learn cutting-edge therapeutic techniques, gain practical experience, and contribute to pioneering research.
Source lists: 360 hours
Delivery: Online + São Paulo, Brazil
No medicine self-experience listed
By Spirit Pharma
Same course category
Psychedelic Pharmacology by Substance is a course that delves into the intricate world eight of psychedelic substances. This comprehensive program provides a thorough exploration of the pharmacological properties, clinical research results, toxicity profiles, and drug interactions associated with a
Delivery: Self-paced + Online
By Alchemy
Same course category
Dr. Sidney Edsall is an integrative psychiatrist with experience in trauma, ketamine-assisted psychotherapy, and psychedelic medicine research. Her background includes clinical work in integrative and hospital settings, as well as trials involving 5-MeO-DMT, psilocybin, and MDMA-assisted psychotherapy.